Arcus Biosciences Inc (NYSE:RCUS)’s traded shares stood at 0.6 million during the last session, with the company’s beta value hitting 0.92. At the close of trading, the stock’s price was $14.59, to imply a decrease of -1.68% or -$0.25 in intraday trading. The RCUS share’s 52-week high remains $25.47, putting it -74.57% down since that peak but still an impressive 11.24% since price per share fell to its 52-week low of $12.95. The company has a valuation of $1.33B, with an average of 853.85K shares over the past 3 months.

Arcus Biosciences Inc (NYSE:RCUS) trade information

After registering a -1.68% downside in the last session, Arcus Biosciences Inc (RCUS) has traded red over the past five days. The stock hit a weekly high of 16.66, dropping -1.68% in its intraday price action. The 5-day price performance for the stock is -12.00%, and -16.58% over 30 days. With these gigs, the year-to-date price performance is -23.61%.

Arcus Biosciences Inc (RCUS) estimates and forecasts

Looking at statistics comparing Arcus Biosciences Inc share performance against respective industry, we note that the company has outperformed competitors. Arcus Biosciences Inc (RCUS) shares are -9.72% down over the last 6 months, with its year-to-date growth rate higher than industry average at 13.49% against 13.30%.

RCUS Dividends

Arcus Biosciences Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Arcus Biosciences Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.